Medical abortion reversal: science and politics meet

被引:7
|
作者
Bhatti, Khadijah Z. [1 ]
Nguyen, Antoinette T. [1 ]
Stuart, Gretchen S. [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC USA
关键词
medical abortion; mifepristone; reversal; MIFEPRISTONE; ACCEPTABILITY; PREGNANCY; SAFETY;
D O I
10.1016/j.ajog.2017.11.555
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medical abortion is a safe, effective, and acceptable option for patients seeking an early nonsurgical abortion. In 2014, medical abortion accounted for nearly one third (31%) of all abortions performed in the United States. State-level attempts to restrict reproductive and sexual health have recently included bills that require physicians to inform women that a medical abortion is reversible. In this commentary, we will review the history, current evidence-based regimen, and regulation of medical abortion. We will then examine current proposed and existing abortion reversal legislation. The objective of this commentary is to ensure physicians are armed with rigorous evidence to inform patients, communities, and policy makers about the safety of medical abortion. Furthermore, given the current paucity of evidence for medical abortion reversal, physicians and policy makers can dispel bad science and misinformation and advocate against medical abortion reversal legislation.
引用
收藏
页码:315 / +
页数:6
相关论文
共 50 条
  • [1] Medication Abortion "Reversal" Laws: How Unsound Science Paved the Way for Dangerous Abortion Policy
    Redd, Sara K.
    AbiSamra, Roula
    Blake, Sarah C.
    Komro, Kelli A.
    Neal, Rachel
    Rice, Whitney S.
    Hall, Kelli S.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2023, 113 (02) : 202 - 212
  • [2] "In patient" medical abortion versus surgical abortion: patient's satisfaction
    Di Carlo, Costantino
    Savoia, Fabiana
    Ferrara, Cinzia
    Sglavo, Gabriella
    Tommaselli, Giovanni Antonio
    Giampaolino, Pierluigi
    Cagnacci, Angelo
    Nappi, Carmine
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (08) : 650 - 654
  • [3] Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic review
    Grossman, Daniel
    White, Kari
    Harris, Lisa
    Reeves, Matthew
    Blumenthal, Paul D.
    Winikoff, Beverly
    Grimes, David A.
    CONTRACEPTION, 2015, 92 (03) : 206 - 211
  • [4] Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation
    Hsia, Jennifer K.
    Lohr, Patricia A.
    Taylor, Jeanette
    Creinin, Mitchell D.
    CONTRACEPTION, 2019, 100 (03) : 178 - 181
  • [5] Update on medical abortion: simplifying the process for women
    Whaley, Natalie S.
    Burke, Anne E.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2015, 27 (06) : 476 - 481
  • [6] Provision of medical abortion using telemedicine in Brazil
    Gomperts, Rebecca
    van der Vleuten, Kirsten
    Jelinska, Kinga
    da Costa, Cecilia Veiera
    Gemzell-Danielsson, Kristina
    Kleiverda, Gunilla
    CONTRACEPTION, 2014, 89 (02) : 129 - 133
  • [7] Early medical abortion
    Cameron, Sharon T.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2025, 99
  • [8] Medical abortion in the late first trimester: a systematic review
    Kapp, Nathalie
    Eckersberger, Elisabeth
    Lavelanet, Antonella
    Rodriguez, Maria Isabel
    CONTRACEPTION, 2019, 99 (02) : 77 - 86
  • [9] Medical abortion is fundamental to women's health care
    Black, Kirsten I.
    Bateson, Deborah
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 (03) : 245 - 247
  • [10] 10-year evaluation of the use of medical abortion through telemedicine: a retrospective cohort study
    Norten, H.
    Ilozumba, O.
    Wilkinson, J.
    Gemzell-Danielsson, K.
    Gomperts, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (01) : 151 - 159